摘要
①目的 探讨达必佳在子宫内膜异位症(EMs)不孕症病人助孕中的作用。②方法 EMs致不孕症病人58例作为EMs组,采用达必佳+尿绒毛膜促性腺激素+尿促性素方案治疗;58 例不明原因不孕症妇女作为对照组,两组均进行体外受精胚胎移植(IVF ET),观察分析助孕过程中MⅡ级卵子数、胚胎质量与妊娠率。③结果 EMs组MⅡ级卵子数目、MⅡ级卵子百分率、Ⅰ级胚胎百分率与对照组比较有显著性差异(t=2.27,χ2 =5.78、6.11,P<0.05);EMs组妊娠率与对照组比较,有统计学差异(χ2=15.88,P<0.01)。④结论 EMs不孕症病人应用达必佳助孕能显著提高妊娠率。
Objective To investigate the role of decapeptyl in assisting reproduction in patients with endometriosis(EMs). Methods Fifty-eight infertile women with endometriosis were treated with Decapeptyl+HMG+HCG(EMs group). Another 58 women with unexplained infertility was served as controls. They were treated by in vitro fertilization-embryo transfer(IVF-ET). The number of M_Ⅱ oocyte and embryo was observed and the pregnancy rate of both groups calculated. Results The amount of follicles and mature oocytes was higher in the EMs group than that in the control(t=2.27,χ 2=5.78-6.11,P<0.05),and the pregnancy rate was also higher than that in the control group(χ 2=15.88,P<0.01). Conclusion Decapeptyl may be helpful in increasing the pregnancy rate in the process of assisted reproduction in women with endometriosis.
出处
《齐鲁医学杂志》
2005年第1期35-36,共2页
Medical Journal of Qilu
